In summary, our study indicates that ANGPTL2 promotes VEGF-A synthesis in human lung cancer cells and subsequently facilitates LEC lymphangiogenesis via the integrin α5β1 receptor, p38 and NF-κB signaling (Figure 7). Here, VEGFA is linked to lung cancer.